219A.T

Research · Aug 25, 2026

Cardiac Cell Therapy Receives First Reimbursed Price in Japan

Japan's conditional approval pathway set a ¥53.2 million reimbursed price for ReHeart, making MHLW the first regulator to price cardiac cell therapy.